Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 126 - 150 of 352
CD3
Immunohistochemistry (IHC)CD3 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD3 IHC Disease T-cell lymphomas and leukaemiasCD3 is a protein complex and T cell co-receptor that is involved in activating both
CD30(Ki-1)
Immunohistochemistry (IHC)CD30(Ki-1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD30 IHC Disease Immunoblastic B cell or anaplastic T cell malignant lymphomasCD30, also known as TNFRSF8, is a cell membrane
CD31
Immunohistochemistry (IHC)CD31 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD31 IHC Disease Angiomas, angiosarcomas, and small lymphocytic and lymphoblastic lymphomasCD31 is a transmembrane protein encoded
CD34
Immunohistochemistry (IHC)CD34 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD34 IHC Disease Acute myeloid leukemia (AML), Acute lymphoblastic leukemia (ALL), Gastrointestinal stromal tumor (GIST), dermatofibrosarcoma
CD35
Immunohistochemistry (IHC)CD35 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD35 IHC Disease Follicular dendritic cell tumor/sarcoma, and MALTomaCD35, complement receptor 1, is a cell membrane-bound, monomeric
CD4
Immunohistochemistry (IHC)CD4 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD4 IHC Disease T CELL neoplasmsCD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting
CD43
Immunohistochemistry (IHC)CD43 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD43 IHC Disease Pan T cell marker Classify subtypes of T cell lymphomas and low grade B cell lymphomas Differentiate
CD45(LCA)
Immunohistochemistry (IHC)CD45(LCA) Alternative Name Leukocyte Common Antigen (LCA) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD45 IHC Disease Confirm the hematopoietic nature of tumors. Highlight
CD5
Immunohistochemistry (IHC)CD5 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD5 IHC Disease Marker for Chronic lymphocytic leukemia (CLL), mantle cell lymphoma (only rarely is CD5-), T cells (normal and malignant),
CD5/PAX5 (Dual)
Immunohistochemistry (IHC)CD5/PAX5 (Dual) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD5/PAX5 IHC Disease Identification of mature and immature B cell neoplasms, and Chronic lymphocytic leukemia (CLL)CD5/PAX5
CD56
Immunohistochemistry (IHC)CD56 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD56 IHC Disease Marker of NK cells and NK lymphomas Detect residual myeloma and residual AML in bone marrow Differentiate
CD57
Immunohistochemistry (IHC)CD57 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD57 IHC Disease Marker of NK cells and neuroendocrine tumors, helps distinguish high grade prostatic adenocarcinoma (CD57+) from
CD61
Immunohistochemistry (IHC)CD61 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD61 IHC Disease Identify platelets,megakaryocytes, megakaryocytic leukemias, platelet thrombi Distinguish TTP (diffuse
CD68
Immunohistochemistry (IHC)CD68 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD68 IHC Disease Histiocytic malignancies are usually CD68 positive. Histiocytic sarcoma Myeloid/monocytic sarcoma, differential
CD7
Immunohistochemistry (IHC)CD7 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD7 IHC Disease T-cell leukemias and myeloid leukemias. CD7 can be aberrantly expressed in refractory anaemia with excess blasts
CD71
Immunohistochemistry (IHC)CD71 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD71 IHC Disease Identifying erythroid precursors in red blood cell hypoplasia and hyperplasia, with or without dyspoietic features,
CD79a
Immunohistochemistry (IHC)CD79a Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD79A IHC Disease General detection of B cells/B cell origin (with CD20); In ALL or small B cell lymphoproliferative disorders
CD8
Immunohistochemistry (IHC)CD8 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD8 IHC Disease Marker of T cells (normal and malignant) Marker of cytotoxic/suppressor T cells Classify lymphomas Differentiate
CD99
Immunohistochemistry (IHC)CD99 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CD99 IHC Disease Small round blue cell tumors, Ewing sarcoma, lymphoblastic leukemias/lymphomas, round and spindle cell sarcomas,
CDX2
Immunohistochemistry (IHC)CDX2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CDX2 IHC Disease GI origin for adenocarcinomas, metastatic adenocarcinoma, intestinal metaplasia of the stomach and intestinal-type
CEA (Monoclonal)
Immunohistochemistry (IHC)CEA (Monoclonal) Alternative Name CEA (Mono) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CEAM IHC Disease Cholangiocarcinoma, colon cancer, cancers of the rectum, pancreas, prostate,
CEA (Polyclonal)
Immunohistochemistry (IHC)CEA (Polyclonal) Alternative Name CEA (Poly) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CEAP IHC Disease Cholangiocarcinoma, colon cancer, cancers of the rectum, pancreas, prostate,
Chromogranin A
Immunohistochemistry (IHC)Chromogranin A Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CHROMO IHC Disease Neuroendocrine tumors, and pheochromocytomaGranin protein located in secretory vesicles of neurons
CK14
Immunohistochemistry (IHC)CK14 Alternative Name Cytokeratin 14 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK14 IHC Disease Chronic lymphocytic leukemia (CLL), diffuse large cell lymphoma (DLBCL), follicular
CK17
Immunohistochemistry (IHC)CK17 Alternative Name Cytokeratin 17 (CK17, K17) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK17 IHC Disease Invasive or in situ ductal carcinoma of breast , bladder carcinoma,
